中证智能财讯万达信息（300168）1月30日晚间披露2025年度业绩预告，预计2025年实现营业收入19.5亿元至21.5亿元；归母净利润亏损5.25亿元至6亿元， 上年同期亏损6.86亿元；扣非净利润亏损5.9亿元至6.85亿元，上年同期亏损7.71亿元。以最新收盘价计算，市净率（LF）约7.89倍，市销率（TTM）约4.74 倍。 以本次披露业绩预告均值计算，公司近年市盈率（TTM）图如下所示： 资料显示，公司主要业务涵盖数智医卫、数智政务、数智金融三大领域，以ICT信息科技创新为公司整体软件解决方案基石，向健康管理、智慧城市方向延 伸发展。 据公告，1.报告期内，公司实现减亏，归属于上市公司股东的净利润同比提升约12%–23%。2.公司通过持续推进降本增效举措，使得人工成本及费用总体支 出规模同比下降，运营效率提升，但营业收入仍无法覆盖运营成本及固定费用开支，导致公司仍处于亏损状态。3.部分资产存在减值迹象，资产组未来经济 利益流入低于预期，部分存货成本高于其可变现净值，经初步评估商誉及存货减值规模约0.7–1.0亿元，较上年同期1.5亿元下降约33%–53%。4.报告期内， 公司预计实现非经常性损益 ...

Core Viewpoint - Wanda Information is focusing on the development of AI applications in various sectors, particularly in healthcare, to enhance digital health solutions and improve public services [2]. Group 1: AI Applications and Collaborations - The company is concentrating on industry AI platforms and intelligent agents, promoting applications such as "AI + public health," "AI + medical services," and "AI + convenience services" [2]. - Wanda Information has made significant advancements in the medical AI field, successfully empowering the core medical circle in the Yangtze River Delta with its self-developed intelligent medical platform [2]. - The company’s subsidiary, Jintang Software, collaborates with DeepSeek to establish a new ecosystem for smart healthcare, introducing an AI intelligent agent named "Jin Xiaotang" that integrates generative large language model technology [2]. Group 2: Intelligent Solutions and Services - The intelligent service system covers a full chain from "data query" to "intelligent analysis" and "decision support," providing various smart solutions for medical applications [2]. - The user interface is redesigned through intelligent dialogue, while clinical aspects include integrated diagnostic assistance and personalized treatment plans [2]. - The management side utilizes intelligent analytics and BI for data visualization and decision support, enhancing medical risk management [2]. Group 3: Innovative AI Products - The company has developed several innovative AI products, including data governance platforms, healthcare knowledge platforms, and AI models for pathology and health report interpretation [2]. - The "Chengshi Ban" national intelligent engine supports high-frequency application scenarios, improving the efficiency of public service processes [2]. - New service models such as "ask while doing" and "ask while checking" have been introduced to embed intelligent services throughout administrative processes, addressing challenges in the AI model for public administration [2].

Core Viewpoint - The company is focusing on the development of industry AI platforms and intelligent applications, particularly in the fields of public health, medical services, and convenience services, while promoting the AI upgrade of its core product, the national health information platform [1] Group 1: AI Development and Applications - The company is advancing its "AI + public health," "AI + medical services," "AI + convenience services," and "AI + industry regulation" initiatives [1] - Significant progress has been made in the medical AI sector, with the development of an intelligent medical platform that empowers the core medical circle in the Yangtze River Delta [1] - The company has established a national intelligent engine base to support high-frequency application scenarios such as "Smart Handling," "One-Stop Service," and "Enjoy Without Application" [1] Group 2: Innovative Service Models - The company has innovated service models like "Ask While Handling" and "Ask While Inspecting," embedding intelligent services throughout the administrative process [1] - These innovations effectively address challenges in the governance AI model, such as the scarcity of deep scenarios, difficulties in transformation, and high security requirements [1] Group 3: AI Product Portfolio - The company has developed a range of AI products, including Shuzhitong, Shuyitong, a medical health knowledge platform, a large model support platform, Baize Xiao medical large model platform, intelligent care boxes for elderly care, pathology AI model services, and Ling Su health report interpretation [1]

Core Insights - The company focuses on the development of industry AI platforms and intelligent agents, promoting applications in public health, medical services, convenience services, and industry regulation [1] - The company has made significant advancements in the medical AI sector, successfully empowering the core medical circle in the Yangtze River Delta with its self-developed intelligent medical platform [1] Business Development - The company is accelerating the implementation of digital health intelligent applications and promoting innovative development of "AI+" applications in the public health sector [1] - The company has established a national intelligent engine base to support high-frequency application scenarios such as "Smart Handling," "One-Stop Service," and "Enjoy Without Application" [1] Product Innovation - The company has developed various AI products, including Shuzhitong, Shuyitong, a medical health knowledge platform, a large model support platform, Baize Xiao medical large model platform, intelligent care boxes for elderly monitoring, pathology AI model services, and Ling Su health report interpretation [1] Financial Performance - For the period from January to September 2025, the company achieved a revenue of 1.329 billion yuan, representing a year-on-year growth of 0.57% [1] - The company reported a net loss of 408 million yuan, which is a year-on-year reduction in loss by 27.07% [1]